loading

Finanzdaten der Minerva Neurosciences Inc-Aktie (NERV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
15.70%
2.8443
3.3741 3.9029 4.5222 4.3667
Depreciation and Amortization
0.07%
0.00136
0.00136 0.00136 0.00136 0.00136
Operating Income/Loss
15.70%
-2.8443
-3.3741 -3.9029 -4.5222 -4.3667
Income/Loss From Continuing Operations Before Tax
15.79%
-2.744
-3.2586 -3.753 -4.272 22.51
Income/Loss From Continuing Operations After Tax
15.79%
-2.744
-3.2586 -3.753 -4.272 22.51
Net Income/Loss
15.79%
-2.744
-3.2586 -3.753 -4.272 22.51
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
7.569
7.569 7.569 - 7.569
Diluted Average Shares
0.00%
7.569
7.569 7.569 -0.0045 7.569
Basic Earnings Per Share
16.28%
-0.36
-0.43 -0.50 -0.56 2.97
Diluted Earnings Per Share
16.28%
-0.36
-0.43 -0.50 -0.56 2.97
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):